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Tuberculosis (TB) is still a global health concern, especially in resource-poor countries 
such as The Gambia. Defining protective immunity to TB is challenging: its patho-
genesis is complex and involves several cellular components of the immune system. 
Recent works in vaccine development suggest important roles of the innate immunity 
in natural protection to TB, including natural killer (NK) cells. NK cells mediate cellular 
cytotoxicity and cytokine signaling in response to Mycobacterium tuberculosis (Mtb). 
NK  cells can display specific memory-type markers to previous antigen exposure; 
thus, bridging innate and adaptive immunity. However, major knowledge gaps exist on 
the contribution of NK cells in protection against Mtb infection or TB. We performed a 
cross-sectional assessment of NK cells phenotype and function in four distinct groups 
of individuals: TB cases pre-treatment (n =  20) and post-treatment (n =  19), and 
household contacts with positive (n = 9) or negative (n = 18) tuberculin skin test (TST). 
While NK cells frequencies were similar between all groups, significant decreases in 
interferon-γ expression and degranulation were observed in NK cells from TB cases 
pre-treatment compared to post-treatment. Conversely, CD57 expression, a marker 
of advanced NK cells differentiation, was significantly lower in cases post-treatment 
compared to pre-treatment. Finally, NKG2C, an activation and imprinted-NK memory 
marker, was significantly increased in TST+ (latently infected) compared to TB cases 
pre-treatment and TST− (uninfected) individuals. The results of this study provide valu-
able insights into the role of NK cells in Mtb infection and TB disease, demonstrating 
potential markers for distinguishing between infection states and monitoring of TB 
treatment response.
Keywords: interferon gamma, cD107a, flow cytometry, cD57, nKg2c, Fc gamma receptor iiia, innate memory, 
natural killer cells
inTrODUcTiOn
With an estimated 10.4 million new tuberculosis (TB) cases and 1.8 million deaths reported in 
2015, TB is the leading cause of death from an infectious disease worldwide (1). The prevalence of 
Mycobacterium tuberculosis (Mtb) infection in Africa is among the highest in the world. Although 
TB treatments have successfully averted approximately 49 million deaths globally in the last 
decades, important gaps still exist in combating the epidemic. For example, there are currently 
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no vaccines against any forms of adult TB (2) and no reliable 
biomarkers to distinguish latent from active TB status and, 
importantly, to determine the risk of developing the disease 
(3, 4). Advancing the understanding of TB immunobiology, 
particularly with regard to innate cells, is critical in developing 
novel interventions to combat TB.
At the site of the infection, interactions between Mtb and 
antigen-presenting cells, such as alveolar macrophages and 
dendritic cells, are the initial step of the anti-Mtb responses and 
lead to the presentation of Mtb antigens to CD4+ and CD8+ T cell 
in the lymph nodes. While the role of B cells can be ambivalent, 
B cells are also known to present Mtb antigens, secrete cytokine, 
and generate Mtb-specific antibodies; each of these events can 
influence the immunological milieu in favor of diverse adaptive 
immune responses, such as Th1, Th2, or Th17. Several immune 
mechanisms, involving CD4+, CD8+, and γδ T cells, have been 
shown to contribute to the control of Mtb after an infection 
has been established (5–8). The most important feature of the 
adaptive immune response to TB is associated with CD4+ T cells 
production of interferon gamma (IFNγ), a critical factor for 
protection against the disease (9), and have been the subject of 
substantial research [reviewed in Ref (10)]. The overall T  cell 
adaptive responses during TB are reviewed elsewhere (3, 11).
In humans, however, the adaptive response to Mtb (measured 
by a positive reaction to a tuberculin skin test (TST) or interferon 
gamma release assay) is characteristically delayed compared with 
other infections. Therefore, engagement and activation of innate 
cells at the infection site is a major form of protection against 
TB (12). In addition to macrophages and dendritic cells, other 
innate cells, such as neutrophils and natural killer (NK) cells, also 
participate in the response to Mtb infection. NK cells are potent 
producers of IFNγ and provide signals to infected dendritic 
cells and macrophages to assist with mycobacteria elimination 
(13–16) [also recently reviewed in Ref. (17)]. Neutrophils have 
been shown to interact with NK cells and promote “licensing” 
of NK cells (i.e., the activation of a necessary inhibitory recep-
tor on NK  cells) (18). Interestingly, depletion of neutrophils 
has been reported to affect NK cell maturation, functions (19), 
and activation (20). These features of neutrophils highlight the 
importance of using whole blood in innate cell response assays 
since neutrophils are generally removed during peripheral 
blood mononuclear cells preparation. Appreciation of the role of 
NK cells during TB has only recently re-emerged and mounting 
evidence suggests that cell-mediated innate immunity against TB 
is a promising new tool against TB (17).
Natural killer cells mediate cellular cytotoxicity and cytokine 
signaling in response to antigens and are important mediators 
of innate immunity. In addition, some NK cells display specific 
memory-type markers to previous antigen exposures, forming a 
bridge between the innate and adaptive immune systems (17). 
Various subsets of NK cells have been described, and each pos-
sesses different levels of cell-mediated cytotoxicity and cytokine 
production (21). Portevin et al. showed that NK cells expressing 
different killer-cell immunoglobulin-like receptors haplotypes 
respond to varying degree to Mtb (22). In humans, infections 
with cytomegalovirus (CMV) (23–25), hepatitis B and C virus 
(26), hantavirus (27), and chikungunya virus (CHIKV) (28) 
lead to imprinted NK  cell receptor repertoires with increased 
frequencies of specific NK  cell subsets. Interestingly, in CMV 
infection, NKG2C+ NK cells are elevated during the acute phase 
of the disease, at which the level then persists up to a year post 
infection (29, 30). In response to CHIKV infection, the repertoire 
of NK cell receptors (activating and inhibitory) has been shown to 
be modulated; the increased in NKG2C+ NK cells with infection 
correlates with viral load (28). In addition, NKG2C genotype 
could be associated with disease state (31, 32) and may affect 
the frequency of NKG2C+ NK cells in adults (33). For example, 
deletion of the KLRC2 gene, which encodes NKG2C, is associ-
ated with psoriasis (34) and may have a role in the control of 
HCMV in children (35) but not in bacterial infection caused by 
Chlamydia trachomatis (32). Thus, the NKG2C genotype may 
have putative functional implication for NK cell activation (36). 
Interestingly, KLRC2 deletion frequency has been shown to 
vary substantially between populations, but the reason for this 
variation remain unknown (32). Although the task of defining 
the physiological role of each NK cell subset is nontrivial, such 
functional characterization could provide the critical knowledge 
for the development of NK  cell-based directed therapy against 
malignancies and infectious diseases.
Evidence for the role of NK cells in the immune response to 
Mtb infection are sparse, especially when we look for human 
cohort from TB-endemic countries, comparison between TB 
patients pre- and post-treatment and latent TB infection, and/or 
analysis of fresh whole blood samples. In TB, NK cells populate 
the granuloma and can help control the infection via different 
mechanisms: (1) directly via cytotoxic activity (e.g., release of 
perforin and granulysin) (37–39), (2) indirectly via signaling to 
the adaptive system (3, 4, 40–42) and possibly via “innate mem-
ory” features (17) such as the specific expansion of the NKG2C+ 
subset as discussed above in other disease models. Nevertheless, 
knowledge about specific NK cell subset distribution (e.g., sur-
face expression levels of Fc receptor, differentiation marker, and 
memory-like marker) and function in relation to TB and Mtb 
infection status in patients are limited (17, 43). This knowledge 
gap impedes the effort in defining protective immunity against 
TB and, consequently, our understanding of TB pathogenesis.
We hypothesized that NK  cell function and subsets in the 
blood can inform both Mtb infection status and the TB treat-
ment response. The objective of this cross-sectional study was to 
provide a description of NK cell function and subset frequencies 
in response to antigenic stimulation, including Mtb-specific anti-
gens, in TB patients and their exposed household contacts (either 
presumed-infected, TST+, or uninfected, TST−). Investigation 
of NK  cell receptor expression, differentiation phenotype, and 
functional characteristics in this study provides further insight 
into the role of NK cells in innate immunity to TB.
MaTerials anD MeThODs
Patient recruitment and Blood sampling
This study was nested within the Medical Research Council 
(MRC) Unit The Gambia (MRCG) Tuberculosis Case Contact 
(TBCC) platform (44) and was approved by the MRCG and 
TaBle 1 | Summary of participant characteristics.
r-cases 
(n = 20)
6mo-cases 
(n = 19)a
TsT+ 
(n = 9)
TsT− 
(n = 18)
Median age,  
years (range)
31.5 (17–65) 30 (18–69) 42 (20–65) 22.5 (16–51)
Female sex, n (%) 5 (25) 6 (23) 8 (89) 14 (78)
FflV + , n (%) 1 (5) 1 (5) 0 0
smear gradeb
3, n (%) 7 (35) 4 (21.1) N/A N/A
2, n (%) 6 (30) 6 (31.6) N/A N/A
l, n (%) 6 (30) 7 (36.8) N/A N/A
neg, n (%) 1 (5) 2 (10.5) N/A N/A
chest X-ray gradec
3, n (%) 14 (70) 14 (73.7) N/A N/A
2, n (%) 5 (25) 5 (26.3) N/A N/A
l, n TO 1 (5) 0 N/A N/A
aA separate group of individuals, who were previously diagnosed with active TB 
and recruited in the TBCC, were also included in this study when they visited the 
clinic for their 6-month post TB treatment follow-up (6mo-cases); i.e., the diagnostic 
assessments (referred to in this table) were performed 6 month prior to their inclusion 
in this study. Refer to the Patient Recruitment and Blood Sampling in the Section 
“Materials and Methods.”
bSmear grade during diagnostic assessment: neg = no disease, 1 = minimal disease. 
2 = moderate disease, 3 = advanced disease.
cChest X-ray grade during diagnostic assessment: 1 = minimal disease, 2 = moderately 
advanced, 3 = far advanced.
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the Gambian Government-Joint Ethics Committee. Following 
written informed consent obtained from patients or parents/
guardians, active smear-positive TB cases (R-cases) and their 
household contacts were recruited. A separate group of indi-
viduals, who were previously diagnosed with active TB and 
recruited by TBCC, were also included in this study when they 
visited the clinic for their 6-month post TB treatment follow-
up (6mo-cases). Individuals with diagnosed active TB disease 
received the standard anti-TB therapy consisting of a 2-month 
intensive phase (daily isoniazid, rifampicin, ethambutol, and 
pyrazinamide) and a 4-month consolidated phase (daily isonia-
zid and rifampicin). Household contacts were further divided 
based on their TST results as TST+ or TST−. Table 1 summarizes 
the participant characteristics for each group. TST was carried 
out with 2 tuberculin units purified protein derivative (PPD, 
RT23, Statens Serum Institute, Copenhagen, Denmark) using 
the Mantoux method. Indurations were recorded at 48–72  h; 
a subject was positive for TST if the induration diameter 
was ≥10 mm. The study participants were ≥16 years old and 
approximately 10 mL of heparinized blood was collected from 
each patient. Absolute count for granulocytes and lymphocytes 
was obtained from whole blood prior to stimulation using the 
Medonic M-series M32 Hematology Analyzer (Boule Medical 
AB, Sweden).
cell stimulation
The blood cell stimulation protocol is based on previously 
published methods (45, 46). Heparinized whole blood from 
the patient was mixed gently with equal ratio of Roswell Park 
Memorial Institute medium (RPMI, Sigma, UK) and 175 µL of the 
mixture was stimulated with phytohemagglutinin (PHA; Sigma, 
UK) (5 µg/mL), recombinant IL-12 (PeproTech, USA) (5 ng/mL) 
and recombinant IL-18 (Medical and Biological Laboratories 
Co Ltd., Japan) (50  ng/mL) (this combination is referred to 
High Concentration Cytokines, HCC), PPD (Staten Institute, 
Denmark, Lot:#231) (10 µg/mL), early secretory antigenic target 
6 culture filtrate protein 10 fusion protein (ESAT-6/CFP10, EC); 
kindly provided by Prof. Tom H. M. Ottenhoff, Leiden University 
Medical Center, or RPMI. All conditions contained low concen-
tration of rIL-12 (12.5 pg/mL) and rIL-18 (10 ng/mL), except for 
HCC. CD107a was added to each well (to a final concentration of 
0.2%) and the plate incubated for 15–16 h at 37°C, 5% CO2. The 
concentrations of PPD and EC, as well as the duration of stimu-
lation, have been previously validated in our laboratory and by 
other groups (47–53). Subsequently, 1X protein transport inhibi-
tor (eBioscience, UK) was added and incubation continued for a 
further 3 hrs. EDTA was then added (final concentration, 2 mM) 
and the strip incubated for another 15 min at 37°C. The content 
from each well was then transferred to pre-filled cryogenic tubes 
containing FACSLyse buffer (1.2 mL; Becton Dickinson, USA), 
inverted to mix gently, and stored immediately at −80°C until 
staining.
intracellular cytokine staining and Flow 
cytometric acquisition
Sample preparation for flow cytometry was performed 
as previously described (45, 46, 54). Briefly, frozen tubes 
were thawed and spun (600  x  g for 5  min). Pellets were then 
suspended in 200  µL of BD FACS Permeabilizing Solution 2 
(Becton Dickinson, USA) and incubated for 10  min in the 
dark. After two washes with FACS buffer (PBS supplemented 
with 5% BSA, 10% NaN3 (all from Sigma, UK), and adjusted 
to pH 7.4–7.6), samples were labeled in a final volume of 
50  µL with a cocktail of fluorochrome-labeled antibodies 
including: CD57 FITC (Cat# 555619 Lot# RRID:AB_395986), 
CD16 PE-CF594 (Cat# 562293 Lot# RRID:AB_11151916), 
CD14 PE-Cy7 (Cat# 557742 Lot# RRID:AB_396848), CD3 
V450 (Cat# 560365 Lot# RRID:AB_1645570), CD45 V500 
(Cat# 560777 Lot# RRID:AB_1937324), CD56 APC (Cat# 
555518 Lot# RRID:AB_398601), IFNγ Alexafluor700 (Cat# 
557995 Lot# RRID:AB_396977), CD8 APC-H7 (Cat# 560179 
Lot# RRID:AB_1645481) (all from BD Biosciences, UK), and 
NKG2C/CD159c PE (R and D Systems USA, Cat# FAB138P 
Lot# RRID:AB_2132983), CD107a BV605 (BioLegend USA, 
Cat# 328634 Lot# RRID:AB_2563851). After staining, samples 
were washed with FACS buffer and immediately acquired on a 
BD Fortessa (Becton Dickinson, USA). Compensation Beads 
(CompBeads; BD Biosciences, UK) were used to standardize 
the voltage settings and used as the single-stain positive and 
negative controls. A total of 400,000 uncompensated events were 
acquired from each sample and compensation was set in FlowJo 
V.10 (FlowJo Tree Star USA, RRID:SCR_008520). Gating dur-
ing analysis was based on the fluorescence-minus-one principle 
(55, 56). Cell viability was assessed via Forward and Side Scatter 
(FSC/SSC) appearance as previously described (45, 54). The 
minimum number of gated cell events accepted for analysis was 
100 events.
4Garand et al. NK Cells and Mtb Infection 
Frontiers in Immunology | www.frontiersin.org February 2018 | Volume 9 | Article 257
statistical analyses
GraphPad Prism v.5 (Graphpad Prism Software USA, 
RRID:SCR_002798) was used for all plots and statistical analy-
ses. For certain cell subsets, the robust regression and outlier 
removal (ROUT) method was used to identify outliers within 
stacks of values (i.e., participant groups) (57). The Kruskal–
Wallis non-parametric test, followed by Dunn’s post  hoc test, 
was used to identify significant differences between groups 
for each cell subset. The effect of stimulation within a subject 
group was analyzed using Freidman test for repeated measured 
with Dunn’s post  hoc test and comparisons were performed 
against the unstimulated condition. The effects of age, HIV, 
smear grade, and chest x-ray grade on cell subset frequencies 
was assessed using generalized linear model (glmnet package 
in R, RRID:SCR_015505) (58). These parameters had no effects 
on the classification model, thus, all results are presented as 
unadjusted values.
resUlTs
Participant characteristics
Table 1 summarizes the participant characteristics. A total of 66 
subjects were included in the study. The median ages for each group 
were comparable except for the TST− group which was lower 
compared to the other groups (non-significant). Participants in 
the R-cases and 6mo-cases groups were majorly male while those 
of TST+ and TST− groups were majorly female. Two (3%) of 
the study participants, belonging to R-cases and 6mo-cases, were 
HIV positive. The distribution of smear grades and chest x-ray 
scores, determined at recruitment into TBCC, was similar for 
individuals in the R-cases and 6mo-cases groups.
Phenotypic assessments
Our phenotypic assessment is based on the gating strategy 
shown in Figure  1A. In R-cases, cell counts for granulocytes 
and lymphocytes were the highest and the lowest, respectively, 
between all participant groups (data not shown). This trend 
is consistent with what was observed in previous reports 
(59, 60). R-cases also exhibited a significant reduction in the 
total frequency of lymphocytes within blood leukocytes, 
indicating a relative enrichment of myeloid lineage (Figure 1B; 
top). Although there was no significant difference in NK  cell 
frequencies between participant groups, a small increase in 
the total frequency of NK  cells (NK defined as CD45+ CD3− 
lymphocytes that expressed CD56) was observed in R-cases 
(Figure 1B; bottom).
CD56, the prototypical marker of NK cells, is a NCAM ligand 
junction type receptor and its expression is conventionally 
characterized as either intermediate (dim) or high (+). Within 
gated NK cells, the frequencies of CD56+ and CD56dim subsets 
were compared to assess whether TB disease status impacted on 
NK cell functional differentiation. The frequencies of CD56+ or 
CD56dim NK cells in the whole blood did not differ significantly 
between groups (Figure 1C). Conversely, expression of CD57, 
a NK  cells marker associated with advanced differentiation 
and reduced cytokine responsiveness (61–63), was found to 
be significantly reduced on NK  cells from 6mo-cases groups 
compared with that of the R-cases and contacts TST− groups 
(Figure 1D; top). However, CD57 expression did not differ among 
R-cases, TST+, and TST− groups, suggestive of a preferential 
expansion of less differentiated CD57− cells in the 6mo-cases. 
The activation receptor NKG2C, which has been associated 
with clonal expansion and augmented effector functions upon 
re-exposure to the antigen (23–30), was examined to address 
the possible involvement of this putative innate memory-type 
marker in TB. The frequencies of NK cells expressing the activa-
tion receptor NKG2C were not found to differ among participant 
groups (Figure 1D bottom).
Changes in the expression of CD16 cells (Fc receptor γRIIIa) 
could affect cytotoxicity-mediated target cell killing. Thus, the 
proportion of CD16+ NK cells between groups were compared 
(Figure 2). Representative dot plots showing subset frequency 
and CD16 median fluorescence intensity for stimulation with 
UN, EC, and PHA are shown in Figure 2A. The expression of 
CD16 was predominant in the CD56dim NK subset. Note that all 
cell subset frequency results presented in text are expressed as 
the median frequency (%) of the parent cell population ± inter-
quartile range [% (Q1–Q3)]. Participants having undergone 
6  months anti-TB treatment exhibited a lowered frequency 
of CD16 expressing cells [33% (22–67)] compared with the 
other group [69% (23–85), 76% (41–85), and 60% (27–77) for 
R-cases, TST+, and TST−, respectively] (Figure 2B). Exposure 
to mycobacterial antigens and inflammatory cytokines down-
regulated CD16 within all groups (Figure 2C). The frequency 
of CD16+ NK  cells is significantly decreased relative to the 
baseline (i.e., unstimulated) for all subjects stimulated with 
HCC and PHA, and for 6mo-cases and TST− groups stimulated 
with EC (Figure  2C). Sustained CD16 downregulation may 
play a role in modulating NK  cells responses (64), therefore 
the extent of CD16 downregulation was compared between 
groups following stimulation. Of note, in the TST+ group, the 
magnitude of the decrease was visually lessen compared with 
downregulation seen in the other participant groups. A large 
inter-individual variation was observed, likely prohibiting any 
significance.
CD57 expression was examined in the context of CD16 
expression; see Figure 3A for examples of dot plots gated from 
the CD56dim CD16+ NK  cell subsets. The 6mo-cases group 
exhibited a non-significant decrease compared with R-cases and 
TST− (Figure  3B). However, when expressed as the CD57−/
CD57+ ratio, this reduction became significant [78% (58–157), 
49% (38–96), and 53% (40–84) for 6mo-cases, R-cases, and 
TST−, respectively] (Figure  3C). While there were no differ-
ences in the frequencies of NKG2C+ NK cells between groups 
(Figure  1D), again, significant differences were observed 
when examined in the context of CD16 expression. Namely, 
the frequency of NKG2C+ cells within the CD56dim CD16− NK 
subset was significantly higher in TST+ compared with that of 
R-cases and TST− [11% (7–15), 3.5% (0.3–7.9), and 2% (1–9.5) 
for TST+, R-cases, and TST−, respectively] (Figure  3D). 
Note that the expression of CD57 and NKG2C within CD16±  
NK subsets remained unchanged with antigenic stimulations 
(data not shown).
FigUre 1 | Continued
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Functional assessment
Natural killer cells are important mediators of innate immune 
response to Mtb via their cytotoxic activity (37, 41). Degranulation 
is one such important mechanism and is measured by cell-surface 
expression of the lysosomal marker LAMP-1/CD107a (65). The 
median frequencies of CD107a+ NK cells in response to Mtb-antigen 
stimulations were compared across the participant groups (see dot 
plots of CD107 expression for R-cases and TST− in Figure 4A). In 
the current study, PHA stimulation induced the highest CD107a+ 
NK  cells frequencies across all groups (Figure  4B; top). After 
stimulation with EC, the frequency of CD107a+ NK cells was sig-
nificantly reduced in R-cases compared with TST+ [2% (1.4–4.5) 
and 6% (4.2–11) for R-cases and TST+, respectively] (Figure 4B; 
top). Non-significant decreases were noted in R-cases compared 
with 6mo-cases and TST− after EC stimulation. PHA stimulation 
induced an increase in CD107a+ NK in TST+ compared with all 
other groups but was similar among all groups after PPD stimula-
tion. HCC stimulation resulted in low numbers of detectable 
events in the CD107a+ gate or frequency that are similar to the 
unstimulated cells; thus, it was not included in the analysis.
FigUre 1 | Impact of Mtb infection status on blood cell and natural killer (NK) cell subsets populations: active TB is characterized by lower lymphocyte frequencies 
and higher granulocyte count. Frequency (expressed as % of parent cell population) of major cell subsets analyzed by flow cytometry (unstimulated condition only). 
(a) Gating strategy with dot plots (the gating order is indicated by numbers). After doublet and debris/dead cells exclusion (plot 1), we identify the following subsets: 
granulocytes (plot 3, based on forward and side scatter appearance; mid-high FSC/high SSC), lymphocytes (plot 4, CD45+/CD14−), monocytes (plot 5, CD45−/
CD14+), natural killer (NK) cells (plot 6, CD3−/CD56dim/+) as well as NK cells expressing CD57, NKG2C (plot 7). (B) Total lymphocytes (% of leukocytes), total NK  
(% of lymphocytes), (c) CD56bright (% of NK), CD56dim (% of NK), and (D) CD57+ (% of NK), and NKG2C+ (% of NK). Each data point represents one subject and 
vertical bars indicate the median ± interquartile range. Comparisons between groups (indicated below the x-axis of the bottom plot in each panel) were made using 
Kruskal–Wallis one-way ANOVA with Dunn’s test as post hoc; where applicable, significance is marked by an asterisk (*) and represents p < 0.01. The x-axis label 
represents the following four groups: (1) individuals with active TB disease = R-cases (open squares, n = 18–20), (2) 6 months post anti-TB treatment = 6mo-cases 
(open circles, n = 18–19), (3) healthy individuals living in the same household as someone with active TB disease and has a positive tuberculin skin test (TST) 
result = TST+ (open triangles, n = 8–9), and (4.) healthy individuals living in the same household as someone with active TB disease and has a negative TST 
result = TST− (open diamonds, n = 18).
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An adequate T helper cells type 1 differentiation and IFNγ 
production are needed to mount a response to mycobacteria 
(10). NK cells are potent producers of IFNγ and signal to infected 
dendritic cells and macrophages necessary for mycobacteria 
elimination (14, 15). The median frequencies of IFNγ+ NK cells 
in response to Mtb-antigen stimulations were compared across 
the participant groups (see dot plots of IFNγ expression for 
R-cases and TST− in Figure  4A). The positive control, HCC, 
induced the highest IFNγ+ cells frequencies regardless of 
participant groups, while levels induced by other stimuli were 
similar (Figure 4B; middle). Significant increases in frequencies 
of IFNγ+ cells, compared with that of R-cases, were observed in 
the 6mo-cases group after stimulation with PPD [3.4% (1.1–5.5) 
and 5.4% (2.3–17) for R-case and 6mo-cases, respectively] and 
HCC [23% (12–30) and 33% (22–48) for R-cases and 6mo-cases, 
respectively] (Figure  4B; middle). The proportion of IFNγ+ 
NK cells was also assessed in CD56dim CD16+, CD56dim CD16−, 
and CD56+ NK subsets with no differences seen between the 
groups; however, non-significant decreases in IFNγ expression 
in CD56+ and CD56dim CD16+ NK subsets from R-cases in 
response to PHA were observed (data not shown). In addition, 
a higher but non-significant proportion of IFNγ-producing cells 
in CD56+ and CD56dim CD16+ NK subsets was noted in the 
TST+ group in response to EC (data not shown).
While the frequency of cells producing only IFNγ did not differ 
drastically among groups, several differences were seen in the fre-
quency of cells with dual functional characteristic (i.e., presence 
of both IFNγ and CD107a) (see dot plots of CD107a and IFNγ 
dual expression for R-cases and TST− in Figure 4A). Frequencies 
were significantly lower in R-cases after PPD (Figure  4B; bot-
tom) and HCC stimulation (data not shown) compared with 
that of 6mo-cases (for PPD stimulation: 1.4% (0.6–3.5) and 2.6% 
(1.4–5.3) for R-cases and 6mo-cases, respectively). R-cases had 
significantly reduced frequency of IFNγ+ CD107a+ NK  cells 
compared to TST+ following EC stimulation [0.7% (0.3–2.6) and 
3.9% (1.8–6) for R-cases and TST+, respectively] and compared 
FigUre 2 | Continued
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FigUre 2 | Impact of Mtb infection status and Mtb-antigen re-exposure on CD16 expression: lower baseline CD16 expression in individual who undergone 
6 months anti-TB treatment compared to the pre-treatment group. The frequency of CD16+ cells [expressed as % CD56dim natural killer (NK) cells] analyzed by flow 
cytometry in the presence or absence of antigenic ligands. (a) Representative dot plots showing CD56 and CD16 expression on NK cells (from the CD3−/CD56dim/+ 
gate) from baseline (UN, top left), with exposure to EC (top right), and PHA (bottom left). CD16 median fluorescence intensity (MFI) is depicted as histograms above 
each plot and summarized in the overlay plot (bottom right). (B) Total CD16+ (% of CD56dim) under unstimulated condition. (c) Total CD16+ (% of CD56dim) 
following incubation with the following antigenic ligands: unstimulated control (UN), purified protein derivative (PPD), ESAT-6/CFP10 fusion protein (EC), high 
concentration of rIL-12 and rIL-18 (HCC), and phytohemagglutinin (PHA). Each data point represents one subject and vertical bars indicate the 
median ± interquartile range. Comparisons between groups (indicated below the x-axis) were made using Kruskal–Wallis one-way ANOVA with Dunn’s test as 
post hoc; where applicable, significance is marked by an asterisk (*) and represents p < 0.01. The effect of stimulation within each group was tested for significance 
using Freidman test for repeated measured with Dunn’s post hoc test and comparisons were performed against UN within each participant group; where applicable, 
significance is marked by an asterisk (*) and represents p < 0.01. The x-axis label represents the four participant groups defined in the legend of Figure 1; R-cases 
(n = 20), 6mo-cases (n = 19), TST+ (n = 9), TST− (n = 17–18).
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to all other groups following PHA stimulation [0.4% (0.2–1.1), 
6.8% (1.4–10), 6.3% (3.2–6.8), and 4.7% (3.4–7.4) for R-cases, 
6mo-cases, TST+, and TST−, respectively] (Figure 4B; bottom).
The frequencies of IFNγ+ and CD107a+ cells were also assessed 
in the context of CD57 and NKG2C expression (Figure  5). 
Except for CD107a+ expression among R-cases and TST+, CD57 
expression had little impact on the general CD107a expression 
trend seen in the CD57− subset (Figures 5A,B). For IFNγ expres-
sion, there was an overall important decrease in the frequency 
of IFNγ+ cells within the CD57+ subset compared to CD57−  
[e.g., 61% (52–67) within CD57− versus 15% (11–31) within 
CD57+ subsets for the TST− group] (Figures  5A,B). CD57 
expression had no effect on the trend and significant differences 
observed among groups with regard to the double-positive cells 
(i.e., CD107a+ IFNγ+); however, the overall frequency was half of 
that of the CD57− subset [e.g., 8% (5.4–12) within CD57− versus 
2.8% (1.3–4) within CD57+ subsets for the TST− group].
The expression of IFNγ+ and CD107a+ in the context of NKG2C 
expression, are shown in Figure 5C. There was a modest increase 
in the overall frequency of CD107a+ cells within the NKG2C+ 
compared to NKG2C− subsets (Figures 5A,C); however, NKG2C 
expression had little impact on the trend seen in the NKG2C− 
subset (Figures 5A,C). Finally, NKG2C expression had no effect 
on the trends and significant differences observed between groups 
with regards to IFNγ+ and double-positive cells (Figures 5A,C).
DiscUssiOn
Early intervention in TB pathogenesis is essential for the manage-
ment of the global TB epidemic. Understanding the involvement 
of innate immunity during Mtb infection is critical, as the initial 
interaction between Mtb and immune cells provides the crucial 
immune cues to effector cells of the adaptive compartment (17, 66). 
Evidence have recently emerged in regard to the importance of 
FigUre 3 | Continued
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FigUre 3 | Impact of Mtb infection status on natural killer cell differentiation and maturity: (1) moderately reduced CD57 expression in individuals with prior Mtb 
exposure, (2) heightened expression of the activation marker NKG2C distinguishes latently infected individuals from active tuberculosis disease and healthy controls. 
Frequency (expressed as % of parent cell population) of major cell subsets analyzed by flow cytometry (unstimulated condition only). (a) Dot plots showing the 
expression of CD57 and NKG2C on CD56dim CD16+ NK cells. Shown is the stimulation with UN, EC, and phytohemagglutinin (PHA) (first, second, and third 
columns, respectively) for individuals in the TST+ (top row) and R-cases (bottom row) groups. (B) Total CD57+ expressed as: % of CD56dim CD16− and% of CD56dim 
CD16+ (left and right, respectively). (c) Ratio of CD57− to CD57+ expressed as% of CD56dim CD16+. (D) Total NKG2C+ expressed as: % of CD56dim CD16− and % of 
CD56dim CD16+ (left and right, respectively). Each data point represents one subject and vertical bars indicate the median ± interquartile range. Comparisons 
between groups (indicated below the x-axis) were made using Kruskal-Wallis one-way ANOVA with Dunn’s test as post hoc; where applicable, significance is 
marked by * for p < 0.05 and ** for p < 0.01. The x-axis label represents the four participant groups defined in the legend of Figure 1; R-cases (n = 19–20), 
6mo-cases (n = 18–19), TST+ (n = 9), TST− (n = 18).
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NK phenotype and function during TB [reviewed in Ref. (17).]. 
In this study, we performed ex vivo whole blood stimulations 
which allowed comparison of NK cell subsets between individu-
als with different Mtb infection status.
The observed significant increase in granulocytes and decrease 
in lymphocytes in R-cases (compared with 6mo-cases and con-
tacts TST−), and the increased proportion of NK cells in R-cases 
(compared with all other groups) were consistent with previous 
reports (3, 59). The lack of differences in the expression of CD56+ 
is also in agreement with a previous report (67), indicating that 
the pre- and post-treatment differences in IFNγ production seen 
in the NK cells in our study is not due to changes in the CD56+ 
population.
CD16, the Fc receptor γRIIIa, is a mediator of antibody-
dependent cell-mediated cytotoxicity and is expressed by NK cells, 
neutrophils, monocytes, and macrophages. Antibody recognition 
by CD16 results in NK cells activation, release of cytolytic granules 
(i.e., degranulation), and target cell killing (40, 68). In the cur-
rent study, participants who had undergone a 6-month anti-TB 
treatment (6mo-cases) exhibited a reduced frequency of CD16 
expressing cells. Downregulation of CD16 following antigen rec-
ognition has been previously described (69–71) and “shedding” 
of CD16 have also been observed in anti-cancer therapy (72) and 
found to be elicited by cytokine and target cell stimulation (21). In 
addition, downregulation of NK CD16 expression following vac-
cination or re-exposure to antigens has also been associated with 
an enhanced antibody response that persisted for several weeks 
(64). Thus, the phenotype we observed in the 6mo-cases may be 
the end result of Mtb clearance. However, we could not exclude 
the contribution of the inter-individual variation in our observa-
tions; thus, further examination using paired patient whole blood, 
pre- and post-treatment, may provide a better assessment of the 
dynamic of CD16 shedding with anti-TB treatment.
A seemingly weak downregulation of CD16, especially fol-
lowing Mtb-specific stimulation, in latently infected individuals 
(i.e., TST+) was also observed. This raised the question whether 
CD16 expression could also be an indicator of disease progres-
sion (i.e., re-activation from latency). Distinct antibody profiles 
in active TB and latent TB patients were recently described by Lu 
et al. (73). The same study also showed that latent TB individuals 
have selective FcγRIII receptor binding, supporting that CD16 
expression can affect Mtb clearance/control. In addition, anti-TB 
antibodies have been described as markers of the disease and its 
progression (74, 75) and evidence suggests a protective role for 
antibodies in TB [reviewed in Ref. (76)]. It would be interesting 
to further examine the potential association between anti-TB 
antibodies and NK cells CD16 expression and how it relates to 
the distinct infection status.
A marked “bi-modal” distribution for the frequency of CD16+ 
NK cells was noted within each participant group; i.e., partici-
pants regroup either near the upper range or near the lower range 
of frequencies. We currently do not have an explanation for this 
bi-modal distribution and our generalized linear model analyses 
confirmed that the participant characteristics (age, HIV, smear 
grade, or chest x-ray grade) do not have any significant effects on 
the results. Nonetheless, the overall trend for the group medians 
was consistent on an individual basis; i.e., the frequency of CD16+ 
NK cells decreased from baseline regardless of the initial baseline 
level. Overall, our results suggest that CD16 on its own could be 
an interesting marker to consider for monitoring the progression 
of anti-TB treatment.
Natural killer cells are important mediators of innate 
immune response to Mtb via their cytotoxic activity (37, 41). 
By assisting with the killing of Mtb-infected cells via degranula-
tion, NK cells help control mycobacterial growth (68). In this 
study, the frequency of CD107a+ NK cells in R-cases was signifi-
cantly reduced compared with the TST+ group only after EC 
stimulation. This suggests that NK cells from active TB patients 
retain the ability for cytotoxic response, but to a lesser extent 
when stimulated with the Mtb-specific antigen EC. NK cells are 
known to diversify their surface receptors via the adaptation 
and response to pathogens, environmental cues (77), and spe-
cific ligands (78). Such diversification results in the expression 
of various patterns of activating and co-stimulatory receptors 
(77). It is likely that changes in the NK cell repertoire during the 
progression of the disease (i.e., from latent to active) resulted 
in the observed differential response to EC. Thus, differences in 
degranulation and CD16 expression between R-cases and TST+ 
could be potential markers for differentiating active disease 
from latency.
Interferon gamma is a well-known critical factor in the 
pro tection against Mtb infection (9) and many diagnostic tools 
of TB are based on IFNγ production upon stimulation with 
Mtb-specific antigens [reviewed in Ref. (3).]. Response to myco-
bacteria and other intracellular pathogen requires an adequate 
T helper cells type 1 (Th1) differentiation and IFNγ production. 
However, there are important discrepancies in the levels of IFNγ 
produced by T cells in response to ex vivo stimulation, especially 
in regard to treatment response (3): IFNγ production in TB cases 
after treatment has been shown to be higher (79, 80), similar 
(81, 82), or lower (82, 83) compared with level before treatment. 
For the most part, the discrepancies have not been attributed to 
FigUre 4 | Continued
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FigUre 4 | Impact of Mtb infection status and Mtb-antigen re-exposure on natural killer (NK) cell function: NK from individuals with active tuberculosis (TB) showed 
markedly reduced interferon gamma (IFNγ) production and moderately reduced degranulation in response to antigenic ligands. The frequency of IFNγ+ and CD107a+ 
cells (expressed as % NK cells) analyzed by flow cytometry in the presence or absence of antigenic ligands. (a) Examples of dot plots showing expression of IFNγ 
and CD107a by NK cells following exposure to purified protein derivative (PPD), EC, phytohemagglutinin (PHA), and HCC as indicated in the R-cases and 
TST− groups (left and right columns, respectively). (B) Total CD107a+ expressed following incubation with PPD, EC, and PHA (top row). Total IFNγ expressed 
following incubation with PPD, EC, and HCC (mid row). Total double-positive cells (i.e., IFNγ+CD107a+) following incubation with PPD, EC, and PHA (bottom row). 
Each data point represents one subject and vertical bars indicate the median ± interquartile range. Comparisons between groups (indicated below the x-axis) were 
made using Kruskal–Wallis one-way ANOVA with Dunn’s test as post hoc; where applicable, significance is marked by * for p < 0.05 and ** for p < 0.01. The x-axis 
label represents the four participant groups defined in the legend of Figure 1; R-cases (n = 20), 6mo-cases (n = 18–19), TST+ (n = 9), TST− (n = 17–18).
FigUre 5 | Impact of Mtb infection status on CD57/NKG2C-defined natural killer (NK) cell subset functional responses to antigenic ligands. The frequency  
of CD107a+, IFNγ+, and double-positive cells (top, mid, and bottom row, respectively) analyzed by flow cytometry in the presence strong antigenic ligands: 
phytohemagglutinin (PHA), HCC, and PHA for CD107a, interferon gamma (IFNγ), and CD107a/IFNγ, respectively. Total functional response expressed as  
(a) % of CD57− NKG2C− NK cells, (B)% of CD57+ NKG2C−, and (c) % of CD57− NKG2C+. Each data point represents one subject and vertical bars indicate  
the median ± interquartile range. Comparisons between groups (indicated below the x-axis) were made using Kruskal–Wallis one-way ANOVA with Dunn’s test  
as post hoc; where applicable, significance is marked by an asterisk (*) and represents p < 0.01. The x-axis label represents the four participant groups defined  
in the legend of Figure 1; R-cases (n = 20), 6mo-cases (n = 18–19), TST+ (n = 9), TST− (n = 16–18).
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any specific parameter and remain unexplained (84) and call for 
the potential role of innate cells as early mediators of protective 
immunity against Mtb infection.
The delayed activation of effector T cells is one of the major 
bottlenecks to Mtb clearance and could be due to an impaired 
signaling to and from innate cells (4). NK cells are potent pro-
ducers of IFNγ and provide signal to infected dendritic cells and 
macrophages to assist with mycobacteria elimination. In this 
study, IFNγ+ NK cells in R-cases were significantly reduced, with 
the greatest difference from that of the 6mo-cases group, indicat-
ing that important functional changes had occurred in NK cells 
following Mtb clearance. Enhancement of IFNγ responses in the 
6mo-cases could result from infection-induced pre-activation 
of NK cells, cytokine-induced memory-like NK cells generation 
(85), and/or help from CD4+ T cells.
In regards to polyfunctionality, Vahlne et al. have described 
the phenotypic differences between IFNγ+, IFNγ+ CD107a+, 
and CD107a+ NK cells and showed that ligands and cell matu-
rity can affect the frequency of each of the phenotypes (86). 
Immature NK  cells mainly express CD107a, thus, are more 
cytotoxic. NK cells of intermediate maturity secrete IFNγ and 
express CD107a, while mature NK  cells mainly secrete IFNγ 
(86). Our results showed that R-cases had the most reduced 
frequency of IFNγ+ and IFNγ+ CD107a+ NK  cells, but were 
able to retain some CD107a+ NK cells at levels similar to that 
of TST− and 6mo-cases groups. This suggests that NK cell in 
R-cases are mostly immature and cytotoxic focused. However, 
additional studies are needed to determine whether the matura-
tion of NK cells, the production of IFNγ, or the accumulation of 
IFNγ is affected specifically in R-cases. Similarly, whether any of 
these processes are the instigating factors for the establishment 
of the disease or consequences of active TB disease remains to 
be investigated.
The surface marker CD57 can be found on ~10–20% of lym-
phocytes, as well as in some epithelial, neural, and chromaffin 
cells (87). Among lymphocytes, CD57 positive cells are typi-
cally T cells or NK cells and are most commonly found in the 
germinal centers of the lymph nodes, tonsils, and spleen (87). 
NK cells expressing CD57 are more differentiated (61, 88). They 
are associated with CD16 expression, less responsive to cytokine 
signaling (62), and produce lower IFNγ in response to antigenic 
stimulation (61). Those characteristics of CD57+ NK cells were 
also observed in the whole blood in this study; i.e., the majority 
of IFNγ+ NK  cells were CD57− while CD107a+ NK  cells were 
CD57+. Significantly less CD57+ NK  cells were also found in 
6mo-cases compared with R-cases and TST−. Together, these 
observations suggest the replenishment of the less differentiated, 
cytokine-responsive, and IFNγ producing NK cell subset follow-
ing Mtb clearance; i.e., a reversal in the repertoire of NK cell sub-
sets. Interestingly, HCMV infection has also been shown to drive 
preferential expansion of CD57+ and NKG2C+ NK population, 
i.e., toward a less cytokine-responsive phenotype (63). Thus, the 
differentiation of NK cell could also be a potential marker of TB 
treatment progression/outcome.
Environmental factors, such as viruses, can have profound 
impact on the functionality and adaptation of innate cells, 
a feature previously ascribed to adaptive immune cells only 
(89). Such environmental impact, such as modulation of innate 
immune responses and susceptibility to infection, is apparent in 
the study by Maertzdorf et al., where NK-associated genes were 
significantly downregulated in active TB patients compared with 
those with latent TB infection (90). These observations suggest 
that NK cells activity is a major controlling factor of Mtb infection 
and that there are significant changes in the NK cell repertoire 
with infection status.
One particular NK-specific surface marker, NKG2C, high-
lights the adaptive nature of NK cells during chronic diseases; i.e., 
the specific expansion of a NK cell subset upon re-exposure with 
specific antigen. NKG2C is an activating receptor which binds 
to HLA-E in a ligand-dependent affinity (91) and is expressed 
mainly on CD56dim NK cells (92, 93). NK cells expressing NKG2C 
are clonally expanded during viral infection (24, 26, 30) and 
have enhanced effector functions [reviewed in Ref. (89)]. Our 
phenotypic results in the whole blood echoed the ideas put forth 
by Rolle and Brodin (89) and the findings of Maertzdorf et  al. 
(90)—the proportion of NKG2C+ CD56dim CD16− NK cells was 
significantly elevated in TST+ compared with levels in R-cases 
and TST−. The increased frequency of imprinted NK  cell 
memory in latently infected individuals, which could be the result 
of repeated Mtb exposure, could play an important role in the 
re-activation of TB. Similar expansion of NKG2C+ NK cell subset 
has also been observed in patients with reactivated CMV (26, 63). 
Furthermore, the lack of differences between pre and post TB 
treatment observed in this study is consistent with the unique 
aspect of NKG2C+ NK cells to have the potential to distinguish 
latent versus active TB.
limitations
A larger sample size could reduce the large inter-individual 
variation observed in the frequencies of the various NK subsets 
as well as improving the power of the statistical comparisons, 
which was quite stringent with the inclusion of multiple com-
parisons correction. However, such inter-individual variability 
could also be the results of surface receptor diversification; e.g., 
CD16 has one of the largest expression diversity among donors 
even though it is a minimally polymorphic receptor (77). In 
addition, Fauriat et al. showed that specific ligands dictate the 
quality and timing of NK cells cytokine production. Therefore, 
the magnitudes of the specific immune responses from NK cells 
are likely graded depending on repertoire of activating receptors 
expressed and utilized (22, 78). Of note, NKG2C genotype may 
contribute/modulate the expansion of NKG2C+ NK cells (31–33, 
36, 94); however, in our study, we did not perform individual 
genotyping of the NKG2C gene. The Mtb strains are another 
important variable as strains have been shown to be associated 
with variation in IFNγ production in response to Mtb antigens 
(95); unfortunately, data on the strains were not available for the 
current study. A gender bias was observed in our study which is 
representative of the recruitment at our study site and can likely 
be explained, in parts, by social factors (96, 97); consequently, 
correcting for gender was not suitable. Lastly, longitudinal 
whole blood samples from active TB patients, i.e., pre- and post-
treatment (paired), would allow for a more direct assessment of 
treatment effect.
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132703 
cOnclUsiOn
We have obtained new insights into the role of NK cells during 
Mtb pathogenesis in a physiologically relevant matrix through 
characterizing the changes in NK cells phenotype and function 
in response to Mtb antigens. Using multicolor flow cytometry, we 
found that NK cells of active TB patients produced significantly 
reduced IFNγ and degranulation in response to Mtb-specific 
antigens. We also noted that TB treatment is associated with a 
lowered frequency of CD57+ NK cells, suggesting an alteration 
of NK repertoire in favoring cells to become more responsive 
to cytokines and activation. There were distinctive differences 
between R-cases and TST+ in respect to CD107a and CD16 
expressing cells, providing future opportunities to distinguish 
active versus latent disease using those markers. In addition, TST+ 
individuals exhibited a higher frequency of NKG2C+ NK cells, 
suggesting that NK cells have gained, from previous exposure to 
Mtb, a primed or licensed NK cell population. These new insights 
gained from this profiling of host immunity characteristic of 
NK cells hold promise as a tool to delineate the immunological 
mechanism involve at different stage of Mtb infection.
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FigUre s1 | Fluorochrome gating controls (all-minus-one). Precise gating for 
key cell populations was controlled using mixes of antibody–fluorochrome pairs 
in which one specific antibody–fluorochrome pair is missing; these mixes are 
called all-minus-(specific target name). As indicated above each dot plot, 
fluorochromes tagged to anti-CD45, CD56, CD16, IFNγ, CD107a, CD57,  
and NKG2C were omitted one-by-one from the antibody mix and gates or 
quadrants were placed in order to have frequency <0.5% detected for that 
missing pair.
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